Track topics on Twitter Track topics that are important to you
London, United Kingdom, February 22, 2017 --(PR.com)-- The two day conference will provide attendees with 5+ hours of networking time, an exclusive post-conference workshop and 16 thought provoking presentations covering the topics of; innovations in drug delivery; nanoparticles, nanomedicine & QbD, CNS drug delivery and therapeutic applications.
Hear from Merck, Novartis, Janssen, Actelion, GSK, Boehringer Ingelheim and many more as they evaluate: generic drug development, biopharmaceutical approaches, oral bioavailability and parenteral drug delivery.
Keynote addresses for Controlled Release Delivery 2017:
René Holm, Head and Scientific Director, Liquids & Parenterals, from Janssen will be presenting on "Lipid suspensions - how, when and with what?" René will discuss:
- What is a lipid based suspension and how could it look from a commercialisation perspective?
- When can lipid based suspensions be used to improve the oral bioavailability?
- How large a proportion of the compound needs to be solubilised in the lipid phase?
- What excipients to use for lipid based formulation?
Mark Wilson, Director, Technology Licensing, PTS from GlaxoSmithKline will be speaking on "The development and commercialisation of drug delivery systems Challenges and opportunities," where he will provide attendees with information on the following:
- GSK’s experiences in developing technologies
- The collaborative “open innovation” approach
- Commercialisation challenges – finding the breakthrough application
- Examples of successful development and exploitation projects
- GSK’s approach to working with other organisations
A full speaker line-up and detailed conference agenda is available to download online at www.controlledreleasedelivery.com/prcom. For those looking to attend, there is currently a £100 discount available which expires on 28th February 2017.
Controlled Release Delivery
Strengthening innovation and overcoming the challenging regulatory landscape
3rd & 4th April 2017
Sponsored by: Avanti Polar Lipids, Buchi, Data Detection Technologies, Precision NanoSystems and Sirius Analytical
For all media enquiries contact Zoe Gale on Tel: +44 (0)20 7827 6032 / Email: email@example.com
To register for the conference, visit www.controlledreleasedelivery.com/prcom or contact Ameenah Begum for group bookings on Tel: +44 (0)20 7827 6166 / Email: firstname.lastname@example.org
To sponsor, speak or exhibit at the conference, contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email: email@example.com
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
+44 (0)20 7827 6132
Contact via Email
Read the full story here: http://www.pr.com/press-release/706148
Press Release Distributed by PR.com
<!--LGfEGNT2Lhm-->Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals. <!--LGfEGNT2Lhm-->Drug delivery technologies are <!--LGfEGNT2Lhm-->patent pr...
Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...